Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alexander Lin, MD
Abramson Cancer Center at Penn Medicine
Principal Investigator - Shannon MacDonald, MD
Massachusetts General Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
40 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- Mayo Clinic-Arizona
Phoenix, Arizona, United States
- Uc San Diego
San Diego, California, United States
- Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- University of Miami Sylvester Cancer Center at Coral Gables
Coral Gables, Florida, United States
- University of Miami Sylvester Cancer Center - Deerfield
Deerfield Beach, Florida, United States
- University of Florida Health
Gainesville, Florida, United States
- University of Florida Health Proton Therapy Institute
Jacksonville, Florida, United States
- Miami Cancer Insititute
Miami, Florida, United States
- University of Miami Sylvester Cancer Center
Miami, Florida, United States
- Orlando Health
Orlando, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Northwestern Medicine Proton Center
Chicago, Illinois, United States
- Willis Knighton
Shreveport, Louisiana, United States
- Johns Hopkins
Baltimore, Maryland, United States
- University of Maryland
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Mass General/north Shore Cancer Center
Danvers, Massachusetts, United States
- Mclaren Proton Therapy
Flint, Michigan, United States
- William Beaumont
Royal Oak, Michigan, United States
- Mayo Clinic-Rochester
Rochester, Minnesota, United States
- Washington University, St. Louis
St Louis, Missouri, United States
- Rwj University Hospital Hamilton
Hamilton, New Jersey, United States
- Cancer Institute of Nj
New Brunswick, New Jersey, United States
- Procure Proton Therapy Center
Somerset, New Jersey, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- New York Proton Center
New York, New York, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- University Hospitals, Case Medical Center
Cleveland, Ohio, United States
- University Pointe, University of Cincinnati
West Chester, Ohio, United States
- Oklahoma University - Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
- Pinnacle Health Cancer Institute
Harrisburg, Pennsylvania, United States
- Abramson Cancer Center at Penn Medicine
Philadelphia, Pennsylvania, United States
- Chester County Hospital
West Chester, Pennsylvania, United States
- Thompson Proton Center
Knoxville, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Texas Center for Proton Therapy
Irving, Texas, United States
- Inova Schar Cancer Institute
Fairfax, Virginia, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Apr 2016
- Primary completion
- 30 Nov 2036
- Completion
- 30 Nov 2036
- Last update posted
- 6 Nov 2025
- Registered enrollment
- 1,238
- Registry id
- NCT02603341
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.